Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
9(32%)
Results Posted
0%(0 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
1
4%
Ph phase_2
6
21%
Ph phase_3
11
39%
Ph phase_4
6
21%
Ph not_applicable
4
14%

Phase Distribution

1

Early Stage

6

Mid Stage

17

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
1(3.6%)
Phase 2Efficacy & side effects
6(21.4%)
Phase 3Large-scale testing
11(39.3%)
Phase 4Post-market surveillance
6(21.4%)
N/ANon-phased studies
4(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

9

trials recruiting

Total Trials

28

all time

Status Distribution
Active(13)
Completed(11)
Terminated(1)
Other(3)

Detailed Status

Completed11
Recruiting8
Not yet recruiting4
unknown3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
9
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.6%)
Phase 26 (21.4%)
Phase 311 (39.3%)
Phase 46 (21.4%)
N/A4 (14.3%)

Trials by Status

unknown311%
active_not_recruiting14%
completed1139%
recruiting829%
terminated14%
not_yet_recruiting414%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT06587737Phase 3

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Not Yet Recruiting
NCT06396858Phase 4

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke

Not Yet Recruiting
NCT06930885Phase 3

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Recruiting
NCT06118034Phase 3

Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery

Recruiting
NCT06798714Phase 4

The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery

Recruiting
NCT05476991Phase 3

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

Recruiting
NCT05785429Not Applicable

The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity

Completed
NCT07035405Phase 3

Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)

Not Yet Recruiting
NCT05873881Phase 3

COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

Recruiting
NCT06763055Phase 3

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

Recruiting
NCT06472908Phase 3

Efficacy and Safety of Colchicine After PCI

Recruiting
NCT05956145Not Applicable

Effect of Low Dose of Colchicine on Platelet Reactivity

Completed
NCT06342609Phase 4

Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease

Completed
NCT05503225Phase 2

Colchicine Use in Intracranial Atherosclerotic Disease

Recruiting
NCT06270225Phase 2

A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.

Active Not Recruiting
NCT06469528Phase 3

ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes

Not Yet Recruiting
NCT04705987Phase 3

Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure

Completed
NCT06078904Phase 4

Different Doses of Colchicine on hsCRP

Completed
NCT06062277Phase 2

COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)

Unknown
NCT04818489Phase 4

Colchicine and Post-COVID-19 Pulmonary Fibrosis

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
28